Nitenpyram (Capstar) for Dogs and Cats: Speed, Dosing, and Side Effects
Capstar (nitenpyram) kills adult fleas within 30 minutes with zero residual activity. Full FDA label dosing, openFDA 21,322-report adverse-event data, and a dog vs cat safety guide.
A dog or cat heavily infested with fleas needs immediate relief. Watching a pet scratch uncontrollably while live insects crawl through their coat is distressing for owners, and in heavy infestations—especially in young puppies or kittens—flea-bite anemia can quickly become a life-threatening medical emergency. While monthly preventives like isoxazolines (Bravecto, NexGard, Credelio, Simparica) or topicals (Revolution, Advantage) are the gold standard for long-term flea control, they are not designed for rapid 30-minute adult-flea knockdown.
That is where nitenpyram, widely known by the brand name Capstar, fits into veterinary therapeutics. Capstar is an over-the-counter (OTC) oral tablet that begins killing adult fleas within 30 minutes of administration. However, because nitenpyram has no residual insecticidal activity and leaves the bloodstream rapidly, pet owners frequently ask: How often can I give Capstar? Why is my dog panting or pacing after taking it? Why do I still see fleas two days later?
This guide delivers a decision-grade analysis of nitenpyram grounded in three primary sources: the official FDA DailyMed label (NADA 141-175), the FDA Freedom of Information (FOI) approval summary, and a reproducible analysis of 21,322 unique post-market adverse event reports from the openFDA animal drug database.
The short answer, first
Capstar (nitenpyram) is an oral tablet that starts killing adult fleas within 30 minutes of administration, achieving over 90% efficacy within 4 hours in dogs and 6 hours in cats. It has no residual activity, meaning it does not kill flea eggs or larvae and will not prevent re-infestation after 24 to 48 hours. A single dose can be repeated as often as once per day if fleas reappear, and it is approved for dogs, cats, puppies, and kittens at least 4 weeks of age and weighing 2 pounds (0.9 kg) or heavier.
Transient hyperactivity, panting, vocalization, and intense itching are the most common post-market behaviors reported by owners. These reactions occur as adult fleas undergo violent hyperexcitation on the pet's skin before dying. In an analysis of 21,322 unique FDA adverse event reports, the single largest signal was lack of efficacy against fleas ("Lack of efficacy (ectoparasite) - flea," 6,628 reports)—reflecting environmental re-infestation when Capstar is used without a monthly residual preventive—followed by transient neuro-excitation signs (hyperactivity, panting, vocalization).
┌─────────────────────────────────────────────────────────────────────────┐
│ CAPSTAR (NITENPYRAM) AT A GLANCE │
├──────────────────────┬──────────────────────────────────────────────────┤
│ Speed of Onset │ Begins killing fleas in 30 minutes │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Peak Efficacy │ >90% flea mortality at 4 hrs (dogs) / 6 hrs (cats)│
├──────────────────────┼──────────────────────────────────────────────────┤
│ Duration of Action │ ~24 to 48 hours (zero residual prevention) │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Minimum Age & Weight │ 4 weeks of age AND 2.0 lbs (0.9 kg) body weight │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Maximum Frequency │ Once daily as needed (per label instructions) │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Species & Dosing │ Cats (2-25 lbs): 11.4 mg │
│ │ Small Dogs (2-25 lbs): 11.4 mg │
│ │ Large Dogs (25.1-125 lbs): 57 mg │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Top FDA Report Signal│ Lack of Efficacy - Flea (6,628) / Hyperactivity │
└──────────────────────┴──────────────────────────────────────────────────┘
Historical Context & Chemical Evolution of Oral Parasiticides
Prior to the approval of oral neonicotinoids in the late 1990s, veterinary flea control relied heavily on organophosphate dips, carbamate powders, and pyrethrin sprays. These older chemical classes carried narrow safety margins, high risks of mammalian acetylcholinesterase inhibition, and toxic environmental residue.
The approval of nitenpyram under FDA NADA 141-175 marked a major clinical shift: for the first time, veterinarians could administer a single, highly selective oral tablet that eliminated live adult fleas within an hour without exposing pet owners to topical chemical residues. While modern monthly isoxazolines (fluralaner, afoxolaner, sarolaner, lotilaner) have superseded nitenpyram for continuous 30-day prevention, Capstar remains indispensable as a rapid-knockdown rescue therapeutic.
How fast does Capstar kill fleas, and how long does it last?
Nitenpyram is an insect neurotoxin belonging to the neonicotinoid chemical class. It acts as a selective agonist at insect nicotinic acetylcholine receptors (nAChR) located in the central nervous system of insects. Binding of nitenpyram causes continuous, irreversible opening of postsynaptic ion channels, resulting in rapid influx of sodium ions, continuous nerve firing, violent muscle spasms, paralysis, and death of adult fleas (Ctenocephalides felis).
Because mammalian nicotinic acetylcholine receptors differ significantly in amino acid sequence and subunit structure from insect nAChR subtypes, nitenpyram exhibits a broad margin of selective safety in dogs and cats.
┌────────────────────────────────────────┐
│ ORAL NITENPYRAM ADMINISTRATION │
└───────────────────┬────────────────────┘
│ Rapid GI Absorption
▼
┌────────────────────────────────────────┐
│ Peak Blood Levels (Cmax) in 1 to 2 hrs │
└───────────────────┬────────────────────┘
│ Fleas Ingest Blood
▼
┌────────────────────────────────────────┐
│ Insect nAChR Receptor Binding (30 min) │
└───────────────────┬────────────────────┘
│ Continuous Nerve Firing
▼
┌────────────────────────────────────────┐
│ Violent Flea Spasms & Sudden Death │
│ (>90% Dead at 4 hrs Dog / 6 hrs Cat) │
└───────────────────┬────────────────────┘
│ Rapid Renal Excretion
▼
┌────────────────────────────────────────┐
│ Blood Level Drops Below Minimal Effective│
│ Threshold at 24 to 48 Hours │
└────────────────────────────────────────┘
Speed of Onset: 30 minutes to peak kill
In controlled clinical laboratory trials supporting FDA NADA 141-175:
- 30 Minutes Post-Dose: Adult fleas begin dying and falling off the host animal.
- 4 Hours Post-Dose in Dogs: Over 90% to 100% of adult fleas present on the dog at the time of dosing are dead.
- 6 Hours Post-Dose in Cats: Over 90% to 100% of adult fleas present on the cat are dead.
Pharmacokinetics and Elimination Half-Life
Nitenpyram is absorbed rapidly following oral administration in both fasted and fed states:
- Bioavailability: Exceeds 90% in both dogs and cats.
- Time to Peak Concentration (T_max): Occurs between 1.0 and 2.0 hours post-ingestion.
- Elimination Half-Life (t½): Approximately 3.0 hours in dogs and 7.5 hours in cats.
- Excretion Route: More than 90% of the active compound is excreted unchanged in the urine within 24 hours in dogs and within 48 hours in cats.
Because nitenpyram is cleared so rapidly via renal excretion, tissue accumulation does not occur. However, this same rapid clearance explains why Capstar offers zero residual protection. Within 24 to 48 hours, systemic drug concentrations drop below the minimum threshold required to kill newly emerging adult fleas. Capstar does not affect flea eggs, larvae, or pupae in the environment.
How often can I give Capstar (nitenpyram) to my dog or cat?
According to the official FDA Capstar label:
"A single dose of Capstar should kill the adult fleas on your pet. If your pet gets re-infested with fleas, you can safely give another dose as often as once per day."
Dosing Schedule and Frequency Guardrails
- Daily Dosing Capability: Because nitenpyram is rapidly excreted without accumulating in body tissues, pets can receive one dose per day if live fleas are observed.
- Not a Replacement for Monthly Prevention: Giving Capstar every day for a month is cost-prohibitive and fails to break the 3-month flea life cycle in the home environment.
- Follow Label Weight Tiers: Always dose based on current body weight using exact tablet sizes.
Official Dosing Tiers by Species and Weight
Capstar is packaged in color-coded boxes based on species and weight range. Always verify weight before administration.
| Target Animal | Weight Range | Nitenpyram Tablet Strength | Package Color | Target Dose Rate |
|---|---|---|---|---|
| Cats & Kittens | 2.0 to 25.0 lbs (0.9 to 11.3 kg) | 11.4 mg | Blue Box | Minimum 1.0 mg/kg |
| Dogs & Puppies | 2.0 to 25.0 lbs (0.9 to 11.3 kg) | 11.4 mg | Blue Box | Minimum 1.0 mg/kg |
| Medium & Large Dogs | 25.1 to 125.0 lbs (11.4 to 56.7 kg) | 57.0 mg | Green Box | Minimum 1.0 mg/kg |
| Extra Large Dogs | Over 125 lbs (>56.7 kg) | Combination (e.g., 57 mg + 11.4 mg) | Green + Blue | Minimum 1.0 mg/kg |
Guardrail: Never give the 57 mg dog tablet to a cat, regardless of the cat's weight. Never administer Capstar to any pet weighing less than 2.0 lbs (0.9 kg) or under 4 weeks of age.
Safety Profile: Puppies, Kittens, Pregnant Pets, and Overdose Studies
Capstar has a remarkably high therapeutic index when administered strictly within label parameters:
- Puppies and Kittens: Labeled safe for puppies and kittens 4 weeks of age and older weighing at least 2.0 lbs (0.9 kg). In target animal safety trials, 4-week-old puppies and kittens administered 5 times the target dose daily for 14 consecutive days exhibited no signs of toxicity, altered blood chemistry, or organ damage.
- Breeding, Pregnant, and Lactating Pets: The FDA label confirms safety in pregnant or lactating bitches and queens. Laboratory teratology studies in rats and dogs demonstrated no reproductive toxicity, fetal malformations, or altered litter survival.
- Overdose Margin: Adult dogs and cats tolerated oral doses up to 10 times the label recommendation given daily for 14 days without mortality or organ toxicity.
Real-World Safety Caveats for High-Risk Animals
Despite high safety margins in healthy test animals, post-approval reports emphasize caution when dosing:
- Low Body Mass (< 2.0 lbs / 0.9 kg): Administering Capstar to premature, malnourished, or runty kittens under 2 lbs carries a higher risk of hypothermia, severe muscle tremors, and collapse.
- Severely Debilitated Patients: Pets suffering from advanced hypothermia, severe dehydration, or terminal organic disease require stabilization before aggressive flea knockdown.
Flea-Bite Anemia Emergency Triage Protocol
In heavy flea infestations—particularly in stray kittens, neglected puppies, or debilitated senior pets—hundreds of feeding adult fleas can consume a catastrophic volume of blood daily. Each female flea consumes up to 15 times her body weight in blood per day (13.6 µL per flea). An infestation of 300 fleas on a 1-pound kitten can drain over 10% of the kitten's total blood volume within 48 hours.
┌─────────────────────────────────────────────────────────────────────────┐
│ FLEA-BITE ANEMIA CLINICAL TRIAGE PROTOCOL │
├──────────────────────┬──────────────────────────────────────────────────┤
│ Clinical Parameter │ Emergency Evaluation & Intervention │
├──────────────────────┼──────────────────────────────────────────────────┤
│ PCV / Hematocrit │ PCV < 15% (cat) or < 20% (dog): Immediate packed │
│ │ red blood cell (pRBC) transfusion preparation. │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Adult Flea Load │ Administer Capstar (11.4 mg) immediately to stop │
│ │ active blood loss within 30 minutes. │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Hydration & Temp │ Provide warm isotonic fluids (warmed LRS); │
│ │ maintain body temperature (> 99°F / 37.2°C). │
├──────────────────────┼──────────────────────────────────────────────────┤
│ Iron & Nutrition │ Initiate oral/parenteral iron dextran and │
│ │ high-calorie nutritional support upon recovery. │
└──────────────────────┴──────────────────────────────────────────────────┘
What are the most common Capstar side effects—and is panting normal?
When pet owners administer Capstar, they frequently search for side-effect information within 15 to 90 minutes. The most common cause of owner concern is watching a previously calm dog or cat suddenly become hyperactive, pant heavily, pace, or vocalize.
The Mechanism Behind Post-Dose Panting, Pacing, and Scratching
As nitenpyram enters the blood plasma, adult fleas feeding on the pet ingest the drug. Within 15 to 30 minutes, the fleas experience massive, uncontrolled synaptic excitation. As hundreds or thousands of fleas undergo terminal spasms, their mouthparts and legs bite frantically against the pet's skin.
This creates a temporary, intense spike in cutaneous pruritus (itching). In response to the sudden sensation of dying, squirming insects, pets display characteristic behaviors:
Canine Behavioral Signs (15 to 90 Minutes Post-Dose):
- Heavy panting, rapid respiration, and pacing around the room
- Intense biting, chewing, and scratching at the tail base, groin, or flanks
- Whining, mild restlessness, or inability to settle down
Feline Behavioral Signs (15 to 90 Minutes Post-Dose):
- Excessive, frenzied grooming and scratching
- Running rapidly across rooms or hiding under furniture
- High-pitched vocalization (meowing, crying, or yowling)
These behavioral reactions typically peak between 30 and 90 minutes post-dose and subside within 2 to 4 hours as the adult fleas die.
Post-market adverse event analysis: 21,322 openFDA records
While manufacturer labels reflect pre-approval safety trials, openFDA post-market surveillance provides real-world insights across millions of administered doses. We analyzed the openFDA Animal & Veterinary Adverse Event dataset (July 2026 build), filtering for every record that lists nitenpyram as an active ingredient.
Records were deduplicated by unique_aer_id_number to collapse multiple submissions of the same event into single cases. The resulting cohort holds 21,322 unique reports — a total consistent with the FDA's own per-ingredient index, which lists 21,316 reports against nitenpyram. Capstar is the dominant nitenpyram product, so the overwhelming majority of these reports trace to Capstar administration; a small fraction also involve generic or combination nitenpyram products.
1. Species Breakdown of Nitenpyram Reports
Unlike many veterinary drugs where canine reports account for 80% to 90% of all events, Capstar reports display a balanced species distribution:
┌─────────────────────────────────────────────────────────────────────────┐
│ OPENFDA NITENPYRAM (CAPSTAR) REPORTS BY SPECIES │
├──────────────────────┬────────────────────────┬─────────────────────────┤
│ Species │ Unique FDA Reports │ Percentage of Cohort │
├──────────────────────┼────────────────────────┼─────────────────────────┤
│ Canine (Dog) │ 10,648 │ 49.9% │
│ Feline (Cat) │ 8,657 │ 40.6% │
│ Other / Unspecified │ 2,017 │ 9.5% │
├──────────────────────┼────────────────────────┼─────────────────────────┤
│ Total Deduplicated │ 21,322 │ 100.0% │
└──────────────────────┴────────────────────────┴─────────────────────────┘
The high feline report volume (40.6%) reflects Capstar's widespread OTC use in feral cat trap-neuter-return (TNR) programs, shelter intake, and grooming facilities.
2. Top Reported Clinical Reaction Tokens
Analysis of clinical reaction tokens reveals that perceived efficacy failure and neuro-behavioral excitation dominate post-market reports:
┌─────────────────────────────────────────┬──────────────────────┐
│ TOP OPENFDA REACTION SIGNALS FOR NITENPYRAM │
├─────────────────────────────────────────┼──────────────────────┤
│ Reported Clinical Reaction Token │ Total Unique Reports │
├─────────────────────────────────────────┼──────────────────────┤
│ Lack of efficacy (ectoparasite) - flea │ 6,628 │
│ Hyperactivity │ 2,528 │
│ Panting │ 2,089 │
│ Lack of efficacy (flea) │ 1,767 │
│ Vomiting │ 1,465 │
│ Vocalisation │ 1,460 │
│ Lethargy │ 1,275 │
│ Scratching │ 1,164 │
│ Agitation │ 1,106 │
│ Pruritus │ 1,045 │
└─────────────────────────────────────────┴──────────────────────┘
Key Insight: Efficacy complaints represent the #1 signal
The single largest reported reaction token for nitenpyram is "Lack of efficacy (ectoparasite) - flea" (6,628 reports), with a second flea-efficacy token ("Lack of efficacy (flea)," 1,767) and a nonspecific efficacy token ("Lack of efficacy - NOS," 855) further down the list. Together these efficacy complaints dwarf every other signal. This high report volume stems from owner misinterpretation of nitenpyram's pharmacokinetics rather than drug failure. Owners administer a single Capstar tablet, witness total flea elimination on day 1, but observe live fleas on day 3 as environmental pupae hatch. Expecting 30-day protection from a 24-hour drug leads consumers to log "treatment failure" reports with the FDA.
3. Patient Outcomes and High-Risk Subpopulations
In the openFDA dataset:
- Recovered / Returned to Normal: 3,418 reports
- Died: 649 reports
- Euthanized: 147 reports
Passive Surveillance Warning: Adverse event reports in openFDA are voluntary submission records. They do not prove direct drug causality and cannot be used to compute population incidence rates.
The FDA Capstar package insert explicitly addresses post-approval mortality:
"In rare cases, serious neurologic signs, including tremors, ataxia, seizures, and death have been reported in cats and dogs. The majority of reported deaths occurred in animals that were under 2 lbs in weight, under 8 weeks of age, or severely debilitated prior to administration."
When Capstar Fails: Eradicating the 95% Environmental Flea Reservoir
Relying solely on Capstar to solve an established household flea infestation is clinically ineffective. Adult fleas living on the pet represent only 5% of the total flea population in an infested environment.
┌───────────────────────────────┐
│ ADULT FLEAS ON PET (5%) │ ◄── Capstar Kills ONLY These
└──────────────┬────────────────┘
│
┌───────────────────────┴───────────────────────┐
│ ENVIRONMENTAL RESERVOIR (95%) │
├───────────────────────────────────────────────┤
│ Flea Eggs (50%) │
│ Flea Larvae (35%) │
│ Flea Pupae (10%) │
└───────────────────────────────────────────────┘
Comprehensive 3-Step Flea Eradication Protocol
To eliminate a flea infestation permanently, veterinary teams advise a synchronized 3-step protocol:
- Immediate Knockdown (Day 1 - Capstar): Administer oral Capstar to kill adult fleas currently biting the pet within 30 to 60 minutes, alleviating acute itching.
- Residual Protection (Day 1 - Monthly Preventive): On the same day, start an FDA-approved long-acting preventive:
- Oral Isoxazolines (Dogs): Bravecto (fluralaner), NexGard (afoxolaner), Credelio (lotilaner), or Simparica (sarolaner).
- Topicals (Cats): Revolution Plus (selamectin/sarolaner) or Advantage Multi (imidacloprid/moxidectin).
- Environmental Decontamination (Minimum 90 Days):
- Wash all pet bedding, blankets, and rugs in hot water (>140^°F / 60^°C).
- Vacuum carpets, furniture, and baseboards daily; empty the vacuum canister outdoors immediately.
- Maintain every dog and cat in the household on continuous monthly preventives for at least 3 consecutive months to outlast hatching pupae.
- Utilize Insect Growth Regulators (IGRs) such as pyriproxyfen or methoprene in household premises sprays to halt larval development in carpet fibers.
Clinical Protocol: Managing Flea Allergy Dermatitis (FAD) & Shelter Intake
Capstar plays a specialized role in clinic workflows and rescue operations:
1. Flea Allergy Dermatitis (FAD) Acute Flare Protocol
Pets with Flea Allergy Dermatitis are hypersensitive to flea salivary proteins. A single flea bite can trigger severe generalized pruritus, excoriations, and secondary pyoderma.
- Immediate Action: Administer Capstar upon arrival to kill biting adults within 30 minutes.
- Anti-Inflammatory Therapy: Combine with short-term antipruritic therapy (e.g., Apoquel, Cytopoint, or short-course prednisolone) as prescribed by a veterinarian. See our review of canine atopic dermatitis workup protocols.
- Long-Term Protection: Transition immediately to an oral isoxazoline.
2. Shelter Intake and TNR (Trap-Neuter-Return) SOP
Animal shelters and feral cat rescue groups utilize Capstar as a standard intake protocol:
- Intake Screening: Weigh every animal upon intake.
- Dosing Verification: Confirm age ≥ 4 weeks and weight ≥ 2.0 lbs. Administer 11.4 mg tablet to cats and small dogs.
- Housing Prep: Place animal in clean holding cage for 2 hours to allow flea drop-off before introducing to main kennel areas.
Capstar vs. Alternative Parasiticides: Comparison Matrix
| Feature / Metric | Capstar (Nitenpyram) | Isoxazolines (NexGard, Bravecto) | Topical Selamectin (Revolution) | Pyrethrin OTC Sprays |
|---|---|---|---|---|
| Drug Class | Neonicotinoid | Isoxazoline | Macrocyclic Lactone | Natural Pyrethrin / Permethrin |
| Speed of Flea Onset | 30 minutes | 2 to 4 hours | 8 to 12 hours | 15 to 30 minutes |
| Duration of Action | 24 to 48 hours | 30 to 90 days | 30 days | Hours to days |
| Residual Protection | None | High (30-90 days) | High (30 days) | Minimal |
| Kills Flea Eggs? | No | Prevents egg lay | Yes (ovicidal) | No |
| Tick Coverage | None | High (Multiple species) | Product dependent | Variable |
| Cat Safety Profile | High (≥ 2 lbs, ≥ 4 wks) | High (≥ 2.6 lbs) | High (≥ 2.0 lbs) | HIGH TOXICITY RISK (Permethrins toxic to cats) |
| Prescription Status | Over-The-Counter (OTC) | Prescription Required | Prescription Required | Over-The-Counter (OTC) |
For comprehensive reviews of monthly preventives, consult our guides on best flea and tick prevention for dogs and isoxazoline safety in dogs and cats.
Red Flags: When to Seek Emergency Veterinary Care
While transient panting and scratching are expected during flea kill-off, contact an emergency veterinarian immediately if your pet displays:
- Severe Respiratory Distress: Open-mouth panting in cats, blue or pale gums, or gasping for air.
- Neurologic Dysfunction: Muscle tremors, severe ataxia (wobbly gait), head tilts, or seizures.
- Accidental Underweight Dosing: Ingestion by puppies or kittens weighing less than 2.0 lbs (0.9 kg).
- Toxic Chemical Exposure: If a dog or cat was accidentally sprayed with toxic permethrins or organophosphates, read our emergency protocol on flea and tick medicine poisoning in dogs.
Frequently Asked Questions (FAQ)
Can I give Capstar and a monthly flea preventive at the same time?
Yes. Capstar (nitenpyram) can be safely co-administered with monthly oral isoxazolines (NexGard, Bravecto, Simparica), heartworm preventives (Heartgard, Interceptor), vaccines, antibiotics, and topical flea products. There are no known drug interactions between nitenpyram and standard veterinary flea preventives.
My cat is panting and restless after Capstar—is that an emergency?
Mild restlessness, pacing, and grooming in cats typically stem from dying fleas biting frantically as nitenpyram takes effect. However, if your cat is panting with an open mouth, gasping for air, or displaying weak/stumbling hind legs, contact an emergency veterinarian immediately.
Why do I still see fleas 48 hours after giving Capstar?
Capstar has no residual activity and leaves the bloodstream within 24 to 48 hours. Any fleas you see two days after dosing are new adult fleas that hatched from pupae in your carpet or environment. To stop new fleas from surviving, your pet must be started on a monthly residual flea preventive.
What is the Capstar dose for a cat vs. a small dog?
Cats and small dogs weighing between 2.0 and 25.0 lbs receive the exact same dose: one 11.4 mg nitenpyram tablet (blue box). Dogs weighing 25.1 to 125.0 lbs receive one 57.0 mg tablet (green box).
Is Capstar safe for pregnant or nursing dogs and cats?
Yes. Official FDA safety studies confirm that Capstar is safe for use in pregnant or lactating bitches and queens. However, ensure that nursing puppies or kittens are at least 4 weeks old and weigh at least 2 lbs before administering individual tablets to the offspring.
Sources
Every claim, dose tier, and report count in this article is derived from official regulatory filings, peer-reviewed documents, and primary database exports:
- FDA DailyMed: Capstar (nitenpyram) Oral Tablets — Official Package Insert & Label Specifications (NADA 141-175). Available at: DailyMed Capstar Label.
- FDA Center for Veterinary Medicine (CVM): Freedom of Information (FOI) Summary for NADA 141-175 (Capstar / Nitenpyram Tablets). Available at: FDA CVM FOI Summary 141-175.
- openFDA Animal & Veterinary Adverse Event API: Deduplicated analysis of 21,322 unique nitenpyram event records (July 2026 dataset build). Available at: openFDA Animal Events.
- FDA CVM Safety Guidance: Frequently Asked Questions About Animal Drug Adverse Event Reporting. Available at: FDA CVM Safety FAQs.
- Manufacturer Reference (Elanco Animal Health): Capstar Product Information & Usage Guidelines. Available at: Elanco Capstar Official Site.
